世界の気管支肺異形成症市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bronchopulmonary Dysplasia Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1017 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、気管支肺異形成症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（サーファクタント補充療法、酸素療法、支持療法、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・気管支肺異形成症の市場動向 ・企業の競争状況、市場シェア ・気管支肺異形成症の種類別市場規模（サーファクタント補充療法、酸素療法、支持療法、その他） ・気管支肺異形成症の用途別市場規模（クリニック、病院、その他） ・気管支肺異形成症の北米市場規模2016-2027（アメリカ、カナダ） ・気管支肺異形成症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・気管支肺異形成症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・気管支肺異形成症の中南米市場規模2016-2027（メキシコ、ブラジル） ・気管支肺異形成症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Chiesi Farmaceutici、Discovery Laboratories、Takeda Pharmaceutical Company、MediPost、Clarassance、Syntrix Biosystems） ・結論

Bronchopulmonary dysplasia, a type of chronic lung disorder, affects newborns, mostly premature and infants. Lungs and bronchi are damaged at the neonatal phase which causes destruction of tiny air sacs known as alveoli. Babies are not born with the disease. The condition is developed when premature infants need aid to breathe for a longer period, leading to inflammation and lung scarring. Infants with this disease exhibit signs and symptoms such as rapid breathing and faster heart rate. The disease is life threatening however, the severity of the disease varies.
The global bronchopulmonary dysplasia treatment market is expected to expand at a steady CAGR during the forecast period. According to the Journal of Clinical Medicine, 10,000 to 15,000 new cases of the disorder are reported each year in the U.S. alone. High prevalence of the diseases is expected to drive the global bronchopulmonary dysplasia treatment market during the forecast period. According to the WHO, 15 million babies are born preterm which is another factor contributing to the growth of the market. Furthermore, government initiatives, favorable reimbursement policies, launch of novel drugs, strong pipeline, rising premature birth cases, and increase in health care expenditure are factors likely to propel the global bronchopulmonary dysplasia treatment market during the forecast period. Long-term side effects of drugs, high cost of treatment, and lack of awareness in developing countries are factors anticipated to restrain the global market during the forecast period.

Market Analysis and Insights: Global Bronchopulmonary Dysplasia Market
The global Bronchopulmonary Dysplasia market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bronchopulmonary Dysplasia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bronchopulmonary Dysplasia market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bronchopulmonary Dysplasia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bronchopulmonary Dysplasia market.

Global Bronchopulmonary Dysplasia Scope and Market Size
Bronchopulmonary Dysplasia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bronchopulmonary Dysplasia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surfactant Replacement Therapy
Oxygen Therapy
Supportive Therapy
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Chiesi Farmaceutici
Discovery Laboratories
Takeda Pharmaceutical Company
MediPost
Clarassance
Syntrix Biosystems

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchopulmonary Dysplasia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surfactant Replacement Therapy
1.2.3 Oxygen Therapy
1.2.4 Supportive Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bronchopulmonary Dysplasia Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bronchopulmonary Dysplasia Market Perspective (2016-2027)
2.2 Bronchopulmonary Dysplasia Growth Trends by Regions
2.2.1 Bronchopulmonary Dysplasia Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bronchopulmonary Dysplasia Historic Market Share by Regions (2016-2021)
2.2.3 Bronchopulmonary Dysplasia Forecasted Market Size by Regions (2022-2027)
2.3 Bronchopulmonary Dysplasia Industry Dynamic
2.3.1 Bronchopulmonary Dysplasia Market Trends
2.3.2 Bronchopulmonary Dysplasia Market Drivers
2.3.3 Bronchopulmonary Dysplasia Market Challenges
2.3.4 Bronchopulmonary Dysplasia Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bronchopulmonary Dysplasia Players by Revenue
3.1.1 Global Top Bronchopulmonary Dysplasia Players by Revenue (2016-2021)
3.1.2 Global Bronchopulmonary Dysplasia Revenue Market Share by Players (2016-2021)
3.2 Global Bronchopulmonary Dysplasia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bronchopulmonary Dysplasia Revenue
3.4 Global Bronchopulmonary Dysplasia Market Concentration Ratio
3.4.1 Global Bronchopulmonary Dysplasia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchopulmonary Dysplasia Revenue in 2020
3.5 Bronchopulmonary Dysplasia Key Players Head office and Area Served
3.6 Key Players Bronchopulmonary Dysplasia Product Solution and Service
3.7 Date of Enter into Bronchopulmonary Dysplasia Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bronchopulmonary Dysplasia Breakdown Data by Type
4.1 Global Bronchopulmonary Dysplasia Historic Market Size by Type (2016-2021)
4.2 Global Bronchopulmonary Dysplasia Forecasted Market Size by Type (2022-2027)

5 Bronchopulmonary Dysplasia Breakdown Data by Application
5.1 Global Bronchopulmonary Dysplasia Historic Market Size by Application (2016-2021)
5.2 Global Bronchopulmonary Dysplasia Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bronchopulmonary Dysplasia Market Size (2016-2027)
6.2 North America Bronchopulmonary Dysplasia Market Size by Type
6.2.1 North America Bronchopulmonary Dysplasia Market Size by Type (2016-2021)
6.2.2 North America Bronchopulmonary Dysplasia Market Size by Type (2022-2027)
6.2.3 North America Bronchopulmonary Dysplasia Market Size by Type (2016-2027)
6.3 North America Bronchopulmonary Dysplasia Market Size by Application
6.3.1 North America Bronchopulmonary Dysplasia Market Size by Application (2016-2021)
6.3.2 North America Bronchopulmonary Dysplasia Market Size by Application (2022-2027)
6.3.3 North America Bronchopulmonary Dysplasia Market Size by Application (2016-2027)
6.4 North America Bronchopulmonary Dysplasia Market Size by Country
6.4.1 North America Bronchopulmonary Dysplasia Market Size by Country (2016-2021)
6.4.2 North America Bronchopulmonary Dysplasia Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Bronchopulmonary Dysplasia Market Size (2016-2027)
7.2 Europe Bronchopulmonary Dysplasia Market Size by Type
7.2.1 Europe Bronchopulmonary Dysplasia Market Size by Type (2016-2021)
7.2.2 Europe Bronchopulmonary Dysplasia Market Size by Type (2022-2027)
7.2.3 Europe Bronchopulmonary Dysplasia Market Size by Type (2016-2027)
7.3 Europe Bronchopulmonary Dysplasia Market Size by Application
7.3.1 Europe Bronchopulmonary Dysplasia Market Size by Application (2016-2021)
7.3.2 Europe Bronchopulmonary Dysplasia Market Size by Application (2022-2027)
7.3.3 Europe Bronchopulmonary Dysplasia Market Size by Application (2016-2027)
7.4 Europe Bronchopulmonary Dysplasia Market Size by Country
7.4.1 Europe Bronchopulmonary Dysplasia Market Size by Country (2016-2021)
7.4.2 Europe Bronchopulmonary Dysplasia Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bronchopulmonary Dysplasia Market Size (2016-2027)
8.2 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Type
8.2.1 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Type (2016-2027)
8.3 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Application
8.3.1 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Application (2016-2027)
8.4 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Region
8.4.1 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bronchopulmonary Dysplasia Market Size (2016-2027)
9.2 Latin America Bronchopulmonary Dysplasia Market Size by Type
9.2.1 Latin America Bronchopulmonary Dysplasia Market Size by Type (2016-2021)
9.2.2 Latin America Bronchopulmonary Dysplasia Market Size by Type (2022-2027)
9.2.3 Latin America Bronchopulmonary Dysplasia Market Size by Type (2016-2027)
9.3 Latin America Bronchopulmonary Dysplasia Market Size by Application
9.3.1 Latin America Bronchopulmonary Dysplasia Market Size by Application (2016-2021)
9.3.2 Latin America Bronchopulmonary Dysplasia Market Size by Application (2022-2027)
9.3.3 Latin America Bronchopulmonary Dysplasia Market Size by Application (2016-2027)
9.4 Latin America Bronchopulmonary Dysplasia Market Size by Country
9.4.1 Latin America Bronchopulmonary Dysplasia Market Size by Country (2016-2021)
9.4.2 Latin America Bronchopulmonary Dysplasia Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bronchopulmonary Dysplasia Market Size (2016-2027)
10.2 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Type
10.2.1 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Type (2016-2027)
10.3 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Application
10.3.1 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Application (2016-2027)
10.4 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country
10.4.1 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Chiesi Farmaceutici
11.1.1 Chiesi Farmaceutici Company Details
11.1.2 Chiesi Farmaceutici Business Overview
11.1.3 Chiesi Farmaceutici Bronchopulmonary Dysplasia Introduction
11.1.4 Chiesi Farmaceutici Revenue in Bronchopulmonary Dysplasia Business (2016-2021)
11.1.5 Chiesi Farmaceutici Recent Development
11.2 Discovery Laboratories
11.2.1 Discovery Laboratories Company Details
11.2.2 Discovery Laboratories Business Overview
11.2.3 Discovery Laboratories Bronchopulmonary Dysplasia Introduction
11.2.4 Discovery Laboratories Revenue in Bronchopulmonary Dysplasia Business (2016-2021)
11.2.5 Discovery Laboratories Recent Development
11.3 Takeda Pharmaceutical Company
11.3.1 Takeda Pharmaceutical Company Company Details
11.3.2 Takeda Pharmaceutical Company Business Overview
11.3.3 Takeda Pharmaceutical Company Bronchopulmonary Dysplasia Introduction
11.3.4 Takeda Pharmaceutical Company Revenue in Bronchopulmonary Dysplasia Business (2016-2021)
11.3.5 Takeda Pharmaceutical Company Recent Development
11.4 MediPost
11.4.1 MediPost Company Details
11.4.2 MediPost Business Overview
11.4.3 MediPost Bronchopulmonary Dysplasia Introduction
11.4.4 MediPost Revenue in Bronchopulmonary Dysplasia Business (2016-2021)
11.4.5 MediPost Recent Development
11.5 Clarassance
11.5.1 Clarassance Company Details
11.5.2 Clarassance Business Overview
11.5.3 Clarassance Bronchopulmonary Dysplasia Introduction
11.5.4 Clarassance Revenue in Bronchopulmonary Dysplasia Business (2016-2021)
11.5.5 Clarassance Recent Development
11.6 Syntrix Biosystems
11.6.1 Syntrix Biosystems Company Details
11.6.2 Syntrix Biosystems Business Overview
11.6.3 Syntrix Biosystems Bronchopulmonary Dysplasia Introduction
11.6.4 Syntrix Biosystems Revenue in Bronchopulmonary Dysplasia Business (2016-2021)
11.6.5 Syntrix Biosystems Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bronchopulmonary Dysplasia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surfactant Replacement Therapy
Table 3. Key Players of Oxygen Therapy
Table 4. Key Players of Supportive Therapy
Table 5. Key Players of Others
Table 6. Global Bronchopulmonary Dysplasia Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bronchopulmonary Dysplasia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bronchopulmonary Dysplasia Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Bronchopulmonary Dysplasia Market Share by Regions (2016-2021)
Table 10. Global Bronchopulmonary Dysplasia Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Bronchopulmonary Dysplasia Market Share by Regions (2022-2027)
Table 12. Bronchopulmonary Dysplasia Market Trends
Table 13. Bronchopulmonary Dysplasia Market Drivers
Table 14. Bronchopulmonary Dysplasia Market Challenges
Table 15. Bronchopulmonary Dysplasia Market Restraints
Table 16. Global Bronchopulmonary Dysplasia Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Bronchopulmonary Dysplasia Market Share by Players (2016-2021)
Table 18. Global Top Bronchopulmonary Dysplasia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchopulmonary Dysplasia as of 2020)
Table 19. Ranking of Global Top Bronchopulmonary Dysplasia Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Bronchopulmonary Dysplasia Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bronchopulmonary Dysplasia Product Solution and Service
Table 23. Date of Enter into Bronchopulmonary Dysplasia Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bronchopulmonary Dysplasia Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Bronchopulmonary Dysplasia Revenue Market Share by Type (2016-2021)
Table 27. Global Bronchopulmonary Dysplasia Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Bronchopulmonary Dysplasia Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Bronchopulmonary Dysplasia Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Bronchopulmonary Dysplasia Revenue Market Share by Application (2016-2021)
Table 31. Global Bronchopulmonary Dysplasia Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Bronchopulmonary Dysplasia Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Bronchopulmonary Dysplasia Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Bronchopulmonary Dysplasia Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Bronchopulmonary Dysplasia Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Bronchopulmonary Dysplasia Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Bronchopulmonary Dysplasia Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Bronchopulmonary Dysplasia Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Bronchopulmonary Dysplasia Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Bronchopulmonary Dysplasia Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Bronchopulmonary Dysplasia Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Bronchopulmonary Dysplasia Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Bronchopulmonary Dysplasia Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Bronchopulmonary Dysplasia Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bronchopulmonary Dysplasia Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bronchopulmonary Dysplasia Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bronchopulmonary Dysplasia Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bronchopulmonary Dysplasia Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bronchopulmonary Dysplasia Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Bronchopulmonary Dysplasia Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Bronchopulmonary Dysplasia Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Bronchopulmonary Dysplasia Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Bronchopulmonary Dysplasia Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Bronchopulmonary Dysplasia Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Bronchopulmonary Dysplasia Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Bronchopulmonary Dysplasia Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bronchopulmonary Dysplasia Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bronchopulmonary Dysplasia Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bronchopulmonary Dysplasia Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bronchopulmonary Dysplasia Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country (2022-2027) & (US$ Million)
Table 63. Chiesi Farmaceutici Company Details
Table 64. Chiesi Farmaceutici Business Overview
Table 65. Chiesi Farmaceutici Bronchopulmonary Dysplasia Product
Table 66. Chiesi Farmaceutici Revenue in Bronchopulmonary Dysplasia Business (2016-2021) & (US$ Million)
Table 67. Chiesi Farmaceutici Recent Development
Table 68. Discovery Laboratories Company Details
Table 69. Discovery Laboratories Business Overview
Table 70. Discovery Laboratories Bronchopulmonary Dysplasia Product
Table 71. Discovery Laboratories Revenue in Bronchopulmonary Dysplasia Business (2016-2021) & (US$ Million)
Table 72. Discovery Laboratories Recent Development
Table 73. Takeda Pharmaceutical Company Company Details
Table 74. Takeda Pharmaceutical Company Business Overview
Table 75. Takeda Pharmaceutical Company Bronchopulmonary Dysplasia Product
Table 76. Takeda Pharmaceutical Company Revenue in Bronchopulmonary Dysplasia Business (2016-2021) & (US$ Million)
Table 77. Takeda Pharmaceutical Company Recent Development
Table 78. MediPost Company Details
Table 79. MediPost Business Overview
Table 80. MediPost Bronchopulmonary Dysplasia Product
Table 81. MediPost Revenue in Bronchopulmonary Dysplasia Business (2016-2021) & (US$ Million)
Table 82. MediPost Recent Development
Table 83. Clarassance Company Details
Table 84. Clarassance Business Overview
Table 85. Clarassance Bronchopulmonary Dysplasia Product
Table 86. Clarassance Revenue in Bronchopulmonary Dysplasia Business (2016-2021) & (US$ Million)
Table 87. Clarassance Recent Development
Table 88. Syntrix Biosystems Company Details
Table 89. Syntrix Biosystems Business Overview
Table 90. Syntrix Biosystems Bronchopulmonary Dysplasia Product
Table 91. Syntrix Biosystems Revenue in Bronchopulmonary Dysplasia Business (2016-2021) & (US$ Million)
Table 92. Syntrix Biosystems Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bronchopulmonary Dysplasia Market Share by Type: 2020 VS 2027
Figure 2. Surfactant Replacement Therapy Features
Figure 3. Oxygen Therapy Features
Figure 4. Supportive Therapy Features
Figure 5. Others Features
Figure 6. Global Bronchopulmonary Dysplasia Market Share by Application: 2020 VS 2027
Figure 7. Clinic Case Studies
Figure 8. Hospital Case Studies
Figure 9. Others Case Studies
Figure 10. Bronchopulmonary Dysplasia Report Years Considered
Figure 11. Global Bronchopulmonary Dysplasia Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Bronchopulmonary Dysplasia Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Bronchopulmonary Dysplasia Market Share by Regions: 2020 VS 2027
Figure 14. Global Bronchopulmonary Dysplasia Market Share by Regions (2022-2027)
Figure 15. Global Bronchopulmonary Dysplasia Market Share by Players in 2020
Figure 16. Global Top Bronchopulmonary Dysplasia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchopulmonary Dysplasia as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Bronchopulmonary Dysplasia Revenue in 2020
Figure 18. Global Bronchopulmonary Dysplasia Revenue Market Share by Type (2016-2021)
Figure 19. Global Bronchopulmonary Dysplasia Revenue Market Share by Type (2022-2027)
Figure 20. North America Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Bronchopulmonary Dysplasia Market Share by Type (2016-2027)
Figure 22. North America Bronchopulmonary Dysplasia Market Share by Application (2016-2027)
Figure 23. North America Bronchopulmonary Dysplasia Market Share by Country (2016-2027)
Figure 24. United States Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bronchopulmonary Dysplasia Market Share by Type (2016-2027)
Figure 28. Europe Bronchopulmonary Dysplasia Market Share by Application (2016-2027)
Figure 29. Europe Bronchopulmonary Dysplasia Market Share by Country (2016-2027)
Figure 30. Germany Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bronchopulmonary Dysplasia Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Bronchopulmonary Dysplasia Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Bronchopulmonary Dysplasia Market Share by Region (2016-2027)
Figure 40. China Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bronchopulmonary Dysplasia Market Share by Type (2016-2027)
Figure 48. Latin America Bronchopulmonary Dysplasia Market Share by Application (2016-2027)
Figure 49. Latin America Bronchopulmonary Dysplasia Market Share by Country (2016-2027)
Figure 50. Mexico Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bronchopulmonary Dysplasia Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Bronchopulmonary Dysplasia Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Bronchopulmonary Dysplasia Market Share by Country (2016-2027)
Figure 56. Turkey Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Bronchopulmonary Dysplasia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Chiesi Farmaceutici Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2016-2021)
Figure 60. Discovery Laboratories Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2016-2021)
Figure 61. Takeda Pharmaceutical Company Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2016-2021)
Figure 62. MediPost Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2016-2021)
Figure 63. Clarassance Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2016-2021)
Figure 64. Syntrix Biosystems Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---